|
Stereotactic radiosurgery can benefit patients with:
- Benign and malignant diseases of the central nervous system.
- Primary malignant brain tumors, metastatic cancer to the brain, benign primary brain tumors and arteriovenous malformations (connected to arteries and veins).
- Lesions near critical brain structures, which make them difficult or dangerous to reach with invasive surgery.
- Small histologically benign neoplasms (tumors in tissue structure), often at the cranial base.
This procedure can also be used in conjunction with
surgery, external beam radiotherapy and chemotherapy
in patients with newly diagnosed or recurrent gliomas
(tumors in nervous tissue) and in patients with brain
metastases (secondary tumors within the brain whose
origins are from cancer in another part of the body).
Fractionated stereotactic radiotherapy is an option for
conditions such as pituitary tumors, acoustic neuromas
(tumors growing from nerves related to hearing) or other
tumors close to critical structures (for example, cranial
nerves). This procedure carries a low risk of long-term
side effects, such as visual or other cranial nerve damage.
There are many benefits
associated with both types of
radiosurgery procedures.
 Back to Previous Page
Back to Sterotactic Radiosurgery
|
